JPS5070516A - - Google Patents

Info

Publication number
JPS5070516A
JPS5070516A JP49092699A JP9269974A JPS5070516A JP S5070516 A JPS5070516 A JP S5070516A JP 49092699 A JP49092699 A JP 49092699A JP 9269974 A JP9269974 A JP 9269974A JP S5070516 A JPS5070516 A JP S5070516A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49092699A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5070516A publication Critical patent/JPS5070516A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP49092699A 1973-08-13 1974-08-13 Pending JPS5070516A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732340911 DE2340911A1 (de) 1973-08-13 1973-08-13 Tetanus-antigen und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
JPS5070516A true JPS5070516A (ja) 1975-06-12

Family

ID=5889613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49092699A Pending JPS5070516A (ja) 1973-08-13 1974-08-13

Country Status (9)

Country Link
US (1) US3968202A (ja)
JP (1) JPS5070516A (ja)
BE (1) BE818797A (ja)
CA (1) CA1030066A (ja)
DE (1) DE2340911A1 (ja)
FR (1) FR2240740B1 (ja)
GB (1) GB1460309A (ja)
LU (1) LU70708A1 (ja)
NL (1) NL7410674A (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5296729A (en) * 1976-02-05 1977-08-13 Shionogi & Co Ltd Mixed vaccin for cyanomycosis
CA1085293A (en) * 1976-02-05 1980-09-09 Yuzuru Homma Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2224591A (en) * 1937-06-14 1940-12-10 Boyd Milford John Antigenic substance
DE1617344B2 (de) * 1967-05-06 1976-04-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines tetanus-impfstoffes
US3522347A (en) * 1968-01-25 1970-07-28 American Cyanamid Co Toxoid compositions

Also Published As

Publication number Publication date
CA1030066A (en) 1978-04-25
LU70708A1 (ja) 1976-08-19
BE818797A (fr) 1975-02-13
FR2240740B1 (ja) 1978-07-21
DE2340911A1 (de) 1975-05-07
GB1460309A (en) 1977-01-06
NL7410674A (nl) 1975-02-17
FR2240740A1 (ja) 1975-03-14
US3968202A (en) 1976-07-06

Similar Documents

Publication Publication Date Title
AU476761B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU474838B2 (ja)
AU476714B2 (ja)
AR199451A1 (ja)
AU476696B2 (ja)
FR2240740B1 (ja)
AU477823B2 (ja)
AR200885A1 (ja)
AR195948A1 (ja)
AR197627A1 (ja)
AU477824B2 (ja)
AR196382A1 (ja)
AR195311A1 (ja)
AR193950A1 (ja)
AR200256A1 (ja)
AR196212Q (ja)
AR196123Q (ja)
AU479562A (ja)
AU479405A (ja)
BG19350A1 (ja)
AU479539A (ja)
BG20057A1 (ja)
AU479521A (ja)